Debates over orphan drug pricing: a meta-narrative literature review
Abstract Rare disease prevalence rates are increasing rapidly worldwide, as are the cost of orphan indication drugs used to treat them, posing significant strain on many healthcare systems. In response, a set of tensions have arisen within academic, activist, advocacy, industry, and policy circles o...
| 1. autor: | |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
BMC
2025-03-01
|
| Seria: | Orphanet Journal of Rare Diseases |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s13023-025-03634-2 |